Sarepta Advances SIRNA Partnership and Sells Stake in Arrowhead
Aug 13 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS ANNOUNCES ADVANCEMENT OF SIRNA COLLABORATION AND SALE OF ARROWHEAD EQUITY INVESTMENT
SAREPTA THERAPEUTICS INC - SAFETY REVIEW TRIGGERS $100 MILLION MILESTONE PAYMENT
SAREPTA THERAPEUTICS INC - SELLS $174 MILLION ARROWHEAD STOCK
SAREPTA THERAPEUTICS INC: EXPECTS TO RELEASE PRELIMINARY DATA FROM PHASE 1/2 STUDY OF SRP-1003 IN H2
SAREPTA THERAPEUTICS : ARROWHEAD WILL REDEEM $50 MILLION OF STOCK FROM CO TO PREFUND HALF OF $100 MILLION MILESTONE PAYMENT DUE TO IT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
SpaceX IPO Guide: Can You Buy SpaceX IPO Shares on Robinhood? How Can Investors in Asia and Europe Buy SpaceX IPO Shares?

Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market

Tradingkey







